Metabolism News and Research

Latest Metabolism News and Research

Discovery offers an avenue for development of novel therapies for Chagas disease

Chagas disease, caused by the protozoan parasite Trypanosoma cruzi, affects some 8 million people worldwide. More than a third develop severe heart or digestive problems with a heightened risk of death.

5 Dec 2022

Exploring the effects of dietary fiber on gut microbiome and inflammatory diseases

Researchers reviewed how dietary fibers modulate the composition and function of gut microbiota.

2 Dec 2022

Research project obtains nearly seven million to study factors that affect human immune system in early life

The first few months and years of life are crucial to the development of the human immune system. This is an important phase as the immune system can define which diseases individuals might develop later in life.

2 Dec 2022

Study implicates gut microbiome health in Parkinson's disease

A new study published in the journal Nature Communications discusses the links between this condition that affects the brain and changes in the gut microbiome that may predate brain changes.

1 Dec 2022

Using cationic nanonmaterials to target visceral adiposity

Researchers have long been working on how to treat obesity, a serious condition that can lead to hypertension, diabetes, chronic inflammation, and cardiovascular diseases.

1 Dec 2022

Early life experiences can affect gene activity more than half a lifetime later

Early life experiences can impact the activity of our genes much later on and even affect longevity, finds a new study in fruit flies led by UCL researchers.

1 Dec 2022

Study provides novel therapeutic targets for enhancing the antitumor immunity of γδ-T cells in diabetes

A research team at LKS Faculty of Medicine, The University of Hong Kong (HKUMed) discovered that high glucose impairs the antitumor activity of immune effector γδ-T cells, which contributes to the increased cancer risk in diabetes and that metabolic reprogramming by glucose control may improve the antitumor activity of γδ-T cells.

30 Nov 2022

SARS-CoV-2 can cause hyperglycemia in cats

In a recent study published in The Journal of Infectious Diseases, researchers explored the association between severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection and hyperglycemia in cats.

30 Nov 2022

Moderate alcohol intake may affect lipoprotein metabolism

A recent Nutrients journal study evaluated the impact of 1-2 drinks of alcohol per day on cardiovascular biomarkers in the cross-over intervention, prospective, and assessor-blinded trial called the Metabolic Imprints of Alcoholic Beverages (MetAl).

30 Nov 2022

New urinary biomarkers could help monitor potential abuse of emerging synthetic cannabinoids

A team of scientists from the National University of Singapore (NUS) has successfully identified the urinary biomarkers of an emerging subclass of synthetic cannabinoids, called OXIZID, to monitor potential abuse.

30 Nov 2022

Meta-analysis reviews the incidence of new-onset diabetes in COVID-19 survivors

Researchers estimated the incidence of new-onset diabetes in survivors of coronavirus disease 2019 (COVID-19) employing random-effects meta-analyses using the generic inverse variance method.

30 Nov 2022

Researchers explore gut microbiome dysbiosis in acute COVID-19 infection and recovery

Researchers assessed the taxonomic characteristics of the intestinal (gut) microbiome in patients with active severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infections.

30 Nov 2022

Broccoli and sprouts improve gut microbiota and reduce inflammation in IBD

Recently, scientists reviewed the role of sulforaphane from cruciferous vegetables (e.g., broccoli) in preventing IBD by regulating inflammation and altering the gut microbiome.

29 Nov 2022

Comparing Mediterranean diet versus low-fat diet for metabolic syndrome

Researchers assess the impact of the Mediterranean diet in comparison to a low-fat diet on the outcomes of metabolic syndromes.

29 Nov 2022

Gut microbial flavonoid catabolite reverses fatty liver disease in mice

Researchers report that a gut microbial catabolite could reduce the cardiometabolic disease burden in mice.

29 Nov 2022

Study shines light on how ultrafine particles promote lung cancer progression

While it may seem common knowledge that smoking is bad for your lungs, if and how ultrafine particles present in cigarette smoke impact the development and progression of lung cancer remains unclear.

29 Nov 2022

UAB and Menkes International Association sign a donation agreement to boost research in Menkes disease

These funds, coming from the Menkes International Association, will allow a research project to search for new biomarkers to establish administration and monitoring protocols for a new drug that could improve the lives of children suffering from this rare disease.

29 Nov 2022

Acute COVID-19 infection disrupts a healthy balance between good and bad gut microbes

In an intensive look at the effects of the virus causing COVID-19 on patients' microbiome – the collection of microorganisms that live in and on the human body – Rutgers scientists found that acute infection disrupts a healthy balance between good and bad microbes in the gut, especially with antibiotic treatment.

28 Nov 2022

Study provides first direct evidence of caffeine's ergogenicity on sprint running in athletics

At the international level of sport, even the smallest advantage can take an athlete from being a mere participant to a podium finisher.

28 Nov 2022

Study reveals a wide variation in the water needs of people around the globe

A new study of thousands of people reveals a wide range in the amount of water people consume around the globe and over their lifespans, definitively spilling the oft-repeated idea that eight, 8-ounce glasses meet the human body's daily needs.

25 Nov 2022

Metabolism News and Research

Latest Metabolism News and Research

Discovery offers an avenue for development of novel therapies for Chagas disease

Exploring the effects of dietary fiber on gut microbiome and inflammatory diseases

Research project obtains nearly seven million to study factors that affect human immune system in early life

Study implicates gut microbiome health in Parkinson's disease

Using cationic nanonmaterials to target visceral adiposity

Early life experiences can affect gene activity more than half a lifetime later

Study provides novel therapeutic targets for enhancing the antitumor immunity of γδ-T cells in diabetes

SARS-CoV-2 can cause hyperglycemia in cats

Moderate alcohol intake may affect lipoprotein metabolism

New urinary biomarkers could help monitor potential abuse of emerging synthetic cannabinoids

Meta-analysis reviews the incidence of new-onset diabetes in COVID-19 survivors

Researchers explore gut microbiome dysbiosis in acute COVID-19 infection and recovery

Broccoli and sprouts improve gut microbiota and reduce inflammation in IBD

Comparing Mediterranean diet versus low-fat diet for metabolic syndrome

Gut microbial flavonoid catabolite reverses fatty liver disease in mice

Study shines light on how ultrafine particles promote lung cancer progression

UAB and Menkes International Association sign a donation agreement to boost research in Menkes disease

Acute COVID-19 infection disrupts a healthy balance between good and bad gut microbes

Study provides first direct evidence of caffeine's ergogenicity on sprint running in athletics

Study reveals a wide variation in the water needs of people around the globe

Real-time Raman monitoring for pharmaceutical hot melt extrusion

Synthetic Psychedelics: A Growing Public Health Concern

How the Vutara VXL simplifies single-molecule imaging